Citadel Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.07M | Sell |
72,000
-36,800
| -34% | -$538K | ﹤0.01% | 7504 |
|
|
2025
Q4 | $1.74M | Sell |
108,800
-8,700
| -7% | -$123K | ﹤0.01% | 6221 |
|
|
2025
Q3 | $1.3M | Buy |
117,500
+48,200
| +70% | +$526K | ﹤0.01% | 6977 |
|
|
2025
Q2 | $587K | Sell |
69,300
-58,000
| -46% | -$465K | ﹤0.01% | 8267 |
|
|
2025
Q1 | $1.02M | Sell |
127,300
-269,100
| -68% | -$2.18M | ﹤0.01% | 6904 |
|
|
2024
Q4 | $3.56M | Sell |
396,400
-18,300
| -4% | -$149K | ﹤0.01% | 4544 |
|
|
2024
Q3 | $3.04M | Buy |
414,700
+217,200
| +110% | +$1.35M | ﹤0.01% | 4756 |
|
|
2024
Q2 | $1.13M | Sell |
197,500
-127,800
| -39% | -$673K | ﹤0.01% | 6348 |
|
|
2024
Q1 | $1.63M | Sell |
325,300
-224,600
| -41% | -$1.52M | ﹤0.01% | 5918 |
|
|
2023
Q4 | $4.94M | Buy |
549,900
+48,500
| +10% | +$399K | ﹤0.01% | 3812 |
|
|
2023
Q3 | $3.9M | Buy |
501,400
+151,700
| +43% | +$1.48M | ﹤0.01% | 4051 |
|
|
2023
Q2 | $3.39M | Sell |
349,700
-75,800
| -18% | -$787K | ﹤0.01% | 4254 |
|
|
2023
Q1 | $4.66M | Buy |
425,500
+168,500
| +66% | +$1.48M | ﹤0.01% | 3936 |
|
|
2022
Q4 | $1.11M | Sell |
257,000
-18,500
| -7% | -$107K | ﹤0.01% | 6610 |
|
|
2022
Q3 | $2.07M | Sell |
275,500
-238,000
| -46% | -$2.06M | ﹤0.01% | 5528 |
|
|
2022
Q2 | $5.16M | Sell |
513,500
-810,600
| -61% | -$9.06M | ﹤0.01% | 3734 |
|
|
2022
Q1 | $16.4M | Sell |
1,324,100
-342,300
| -21% | -$5.29M | ﹤0.01% | 2240 |
|
|
2021
Q4 | $38.1M | Buy |
1,666,400
+504,200
| +43% | +$11.9M | 0.01% | 1396 |
|
|
2021
Q3 | $25.7M | Buy |
1,162,200
+402,900
| +53% | +$6.39M | 0.01% | 1710 |
|
|
2021
Q2 | $9.84M | Sell |
759,300
-91,000
| -11% | -$1.16M | ﹤0.01% | 3105 |
|
|
2021
Q1 | $11M | Buy |
850,300
+350,400
| +70% | +$5.08M | ﹤0.01% | 2834 |
|
|
2020
Q4 | $6.91M | Buy |
499,900
+349,400
| +232% | +$5.09M | ﹤0.01% | 3140 |
|
|
2020
Q3 | $2.22M | Buy |
150,500
+16,100
| +12% | +$233K | ﹤0.01% | 4530 |
|
|
2020
Q2 | $2.18M | Sell |
134,400
-43,200
| -24% | -$692K | ﹤0.01% | 4408 |
|
|
2020
Q1 | $2.58M | Sell |
177,600
-145,800
| -45% | -$2.57M | ﹤0.01% | 3725 |
|
|
2019
Q4 | $6.55M | Sell |
323,400
-115,700
| -26% | -$1.07M | ﹤0.01% | 2734 |
|
|
2019
Q3 | $2.35M | Buy |
439,100
+407,000
| +1,268% | +$2.46M | ﹤0.01% | 4230 |
|
|
2019
Q2 | $211K | Buy |
32,100
+11,600
| +57% | +$73.9K | ﹤0.01% | 8115 |
|
|
2019
Q1 | $133K | Sell |
20,500
-19,800
| -49% | -$131K | ﹤0.01% | 8435 |
|
|
2018
Q4 | $275K | Sell |
40,300
-9,200
| -19% | -$53.1K | ﹤0.01% | 7416 |
|
|
2018
Q3 | $329K | Buy |
49,500
+9,900
| +25% | +$55.5K | ﹤0.01% | 7418 |
|
|
2018
Q2 | $223K | Sell |
39,600
-4,400
| -10% | -$24.5K | ﹤0.01% | 7701 |
|
|
2018
Q1 | $228K | Sell |
44,000
-71,600
| -62% | -$383K | ﹤0.01% | 7146 |
|
|
2017
Q4 | $524K | Buy |
115,600
+28,500
| +33% | +$158K | ﹤0.01% | 5579 |
|
|
2017
Q3 | $546K | Buy |
87,100
+5,800
| +7% | +$36.6K | ﹤0.01% | 5195 |
|
|
2017
Q2 | $498K | Sell |
81,300
-111,500
| -58% | -$751K | ﹤0.01% | 5112 |
|
|
2017
Q1 | $1.42M | Buy |
+192,800
| New | +$891K | ﹤0.01% | 3506 |
|
Other funds holding AUPH
TCM
NMC
